Across TCGA pan-cancer cohorts, IGKV2OR2-8 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of IGKV2OR2-8’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where IGKV2OR2-8 RNA is repressed in tumor relative to normal tissue. In most cancer types IGKV2OR2-8 is over-expressed in tumor, although a few such as COAD and STAD show the opposite, repressed pattern.
COAD, STAD, and LUAD are the cancer types where IGKV2OR2-8 tumor–normal differential expression is most reproducible.